Bio-Rad Laboratories
(NYSE) BIO
Bio-Rad Laboratories Financials at a Glance
Market Cap
$8.05B
Revenue (TTM)
$2.59B
Net Income (TTM)
$168.80M
EPS (TTM)
$6.07
P/E Ratio
49.51
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$299.98
Volume
481,973
Open
$296.80
Price
$299.98
Volume
481,973
Open
$296.80
Previous Close
$300.79
Daily Range
$293.46 - $305.00
52-Week Range
$236.73 - $343.12
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
0.94 (Low)
Price
$299.98
Volume
481,973
Open
$296.80
Previous Close
$300.79
Daily Range
$293.46 - $305.00
52-Week Range
$236.73 - $343.12
Estimated Earnings Date
Jul 30, 2026
BIO News
BIO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Rad Laboratories
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
7,400
CEO
Norman D. Schwartz
Website
www.bio-rad.comHeadquarters
Hercules, CA 94547, US
BIO Financials
Key Financial Metrics (TTM)
Gross Margin
51.87%
Operating Margin
9.25%
Net Income Margin
6.52%
Return on Equity
2.40%
Return on Capital
3.01%
Return on Assets
1.72%
Earnings Yield
2.02%
Dividend Yield
0.00%
Payout Ratio
19.73%
Stock Overview
Market Cap
$8.05B
Shares Outstanding
26.76M
Volume
481.97K
Avg. Volume
382.75K
Financials (TTM)
Gross Profit
$1.34B
Operating Income
$239.50M
EBITDA
$469.70M
Operating Cash Flow
$510.40M
Capital Expenditure
-$153.20M
Free Cash Flow
$357.20M
Cash & ST Invst.
$1.56B
Total Debt
$1.38B
Bio-Rad Laboratories Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$592.10M
+1.1%
Gross Profit
$309.40M
+1.1%
Gross Margin
52.25%
N/A
Market Cap
$8.05B
N/A
Market Cap/Employee
$1.05M
N/A
Employees
7,700
N/A
Net Income
-$527.10M
-923.6%
EBITDA
-$636.60M
-576.9%
Quarterly Fundamentals
Total Cash
$1.56B
-5.8%
Total Debt
$1.38B
+0.6%
Accounts Receivable
$426.20M
+0.4%
Inventory
$770.50M
-2.5%
Long Term Debt
$941.50M
-29.1%
Short Term Debt
$436.70M
+927.5%
Return on Assets
1.72%
N/A
Return on Invested Capital
2.70%
N/A
Free Cash Flow
$78.10M
-18.2%
Operating Cash Flow
$108.10M
-16.8%